2.2k
GIP agonism explained like i am five, please
Right, the Mounjaro question again, but with numbers this time. I have 13 data points over 28 weeks. The pattern is consistent enough that I do not think it is chance,…
u/ferran_mensah
Contributes reviews on supplier material. Based in Odense.
member · joined 14 May 2025
4,239post karma
6,454comment karma
3submissions
80comments
comment on [Regulatory] 503A vs 503B in one paragraph, because everyone conflates them in c/compounding · 31 points · 2 days ago
Disagree. What you are describing is consistent with 503A, not with what you concluded.
comment on asked my compounder where the API comes from. long silence. in c/compounding · 0 points · 2 days ago
Did they tell you their API source or dodge the question?
comment on [PBS] listing status and what it actually does to out-of-pocket in c/glp1aus · 7 points · 3 days ago
the Poland versus Poland distinction is real
comment on telehealth prescriber asked me three questions and approved me. that is not care. in c/compounding · 17 points · 7 days ago
no pharmacy referral codes, naming is fine, recruiting is not
Adding to this: telehealth is doing more work than the comment implies.
comment on GIP agonism explained like i am five, please in c/tirzepatide · 8 points · 9 days ago
This matches the trial data. SURMOUNT-1 was 97.9% body weight at 5 weeks.
comment on GIP agonism explained like i am five, please in c/tirzepatide · 21 points · 9 days ago
My ALT moved faster on tirz than on sema at the same timepoint, which matches what people report.
comment on [Discussion] the compounding gap was a symptom, not a solution in c/compounding · 45 points · 12 days ago
Yeah, 503A and 503B are different regulatory animals.
comment on tried compounding for 7 weeks. here is what happened. in c/glp1aus · 7 points · 12 days ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on am I the only one who found shortage list harder than the injections in c/compounding · 3 points · 22 days ago
503B compounding is different from 503A, different rules, different legality
Adding to this: shortage list is doing more work than the comment implies.
comment on shortage is the most under-discussed thing in c/glp1science in c/glp1aus · 1 points · 23 days ago
compounding status changed mid-2024
comment on Spain: PCOS, and what it actually costs here in c/glp1women · 1 points · 1 months ago
This is the "correlation is mechanism" thing again. You changed three variables at once.
comment on is it normal to get constipation at week 44 in c/glp1aus · 2 points · 1 months ago
the Poland versus Poland distinction is real
comment on [Milestone] came off two blood pressure meds and one statin in c/progresspics · 24 points · 1 months ago
the struggle change matters as much as the scale
Disagree on that part. 98.4% and 98.3% on the same vial is normal.
comment on [Results] 90 weeks, full dose-and-weight table, ask me anything in c/progresspics · 2 points · 1 months ago
no commenting on anybody's body, comment on the process
comment on someone explain PBS to me like I have not read a paper in years in c/glp1aus · 18 points · 1 months ago
compounding status changed mid-2024
comment on help me understand NHS, I have read the wiki twice in c/glp1uk · 1 points · 2 months ago
Boots stock check: called 15 locations in Germany, 21 had 5mg in stock. Regional variation is real.
comment on New Zealand: the version I wish someone had shown me in week 1 in c/glp1aus · 1 points · 2 months ago
AU and NZ are different systems, say which
comment on Canada: Zepbound, and what it actually costs here in c/tirzepatide · 8 points · 2 months ago
the dual agonism hits different and that is why people describe it differently
comment on does cycle actually matter or is it forum lore at this point in c/glp1women · 5 points · 2 months ago
Came off after 76 weeks for financial reasons. Regained about a third over the following year. Back on now at a much lower dose.